Entity Details

Primary name IL4
Entity type gene
Source Source Link

Details

PrimaryID3565
RefseqGeneNG_023252
SymbolIL4
Nameinterleukin 4
Chromosome5
Location5q31.1
TaxID9606
Statuslive
SourceGenomegenomic
SourceOriginnatural
CreationDate1989-04-13
ModificationDate2021-06-22

Ontological Relatives

UniProt IDsIL4_HUMAN

GO terms

Show/Hide Table
GOName
GO:0000122 negative regulation of transcription by RNA polymerase II
GO:0001774 microglial cell activation
GO:0002227 innate immune response in mucosa
GO:0002230 positive regulation of defense response to virus by host
GO:0002674 negative regulation of acute inflammatory response
GO:0002677 negative regulation of chronic inflammatory response
GO:0005125 cytokine activity
GO:0005136 interleukin-4 receptor binding
GO:0005576 extracellular region
GO:0005615 extracellular space
GO:0006955 immune response
GO:0008083 growth factor activity
GO:0008203 cholesterol metabolic process
GO:0008284 positive regulation of cell population proliferation
GO:0010628 positive regulation of gene expression
GO:0010633 negative regulation of epithelial cell migration
GO:0016239 positive regulation of macroautophagy
GO:0019221 cytokine-mediated signaling pathway
GO:0030183 B cell differentiation
GO:0030335 positive regulation of cell migration
GO:0030890 positive regulation of B cell proliferation
GO:0031296 B cell costimulation
GO:0032720 negative regulation of tumor necrosis factor production
GO:0032733 positive regulation of interleukin-10 production
GO:0032736 positive regulation of interleukin-13 production
GO:0042092 type 2 immune response
GO:0042102 positive regulation of T cell proliferation
GO:0042110 T cell activation
GO:0042116 macrophage activation
GO:0042325 regulation of phosphorylation
GO:0042531 positive regulation of tyrosine phosphorylation of STAT protein
GO:0042976 activation of Janus kinase activity
GO:0043011 myeloid dendritic cell differentiation
GO:0043031 negative regulation of macrophage activation
GO:0043066 negative regulation of apoptotic process
GO:0043306 positive regulation of mast cell degranulation
GO:0045064 T-helper 2 cell differentiation
GO:0045191 regulation of isotype switching
GO:0045348 positive regulation of MHC class II biosynthetic process
GO:0045582 positive regulation of T cell differentiation
GO:0045671 negative regulation of osteoclast differentiation
GO:0045892 negative regulation of transcription, DNA-templated
GO:0045893 positive regulation of transcription, DNA-templated
GO:0045944 positive regulation of transcription by RNA polymerase II
GO:0048260 positive regulation of receptor-mediated endocytosis
GO:0048295 positive regulation of isotype switching to IgE isotypes
GO:0048304 positive regulation of isotype switching to IgG isotypes
GO:0050728 negative regulation of inflammatory response
GO:0050776 regulation of immune response
GO:0071677 positive regulation of mononuclear cell migration
GO:0097028 dendritic cell differentiation
GO:0097192 extrinsic apoptotic signaling pathway in absence of ligand
GO:0120162 positive regulation of cold-induced thermogenesis
GO:0150076 neuroinflammatory response
GO:0150079 negative regulation of neuroinflammatory response
GO:1900223 positive regulation of amyloid-beta clearance
GO:1901741 positive regulation of myoblast fusion
GO:1901857 positive regulation of cellular respiration
GO:1903660 negative regulation of complement-dependent cytotoxicity
GO:1903845 negative regulation of cellular response to transforming growth factor beta stimulus
GO:2000320 negative regulation of T-helper 17 cell differentiation
GO:2000352 negative regulation of endothelial cell apoptotic process
GO:2000424 positive regulation of eosinophil chemotaxis
GO:2000553 positive regulation of T-helper 2 cell cytokine production
GO:2001171 positive regulation of ATP biosynthetic process
GO:2001237 negative regulation of extrinsic apoptotic signaling pathway

Diseases

Show/Hide Table
Disease IDSourceNameDescription
601367 OMIMIschemic stroke (ISCHSTR)A stroke is an acute neurologic event leading to death of neural tissue of the brain and resulting in loss of motor, sensory and/or cognitive function. Ischemic strokes, resulting from vascular occlusion, is considered to be a highly complex disease consisting of a group of heterogeneous disorders with multiple genetic and environmental risk factors. Disease susceptibility is associated with variants affecting the gene represented in this entry.

Interactions

7 interactions